Consistent with this hypothesis, we found that SPARC methylation levels in NSCLC were associated in our cohort with high methylation levels in SqCC and are able to predict patients’ survival since it identified early stage patients with significant shorter survival after surgical resection. The gene discussed is SPARC; the disease is non-small cell lung carcinoma.